CXCR3 receptor as new target to treat neuropathic pain: efficacy of a receptor antagonist in in vitro and in vivo studies
Authors: Piotrowska A., Kwiatkowski K., Rojewska E., Pawlik K., Ciechanowska A., Mika J.
Published in: European Pain Federation Krakow Pain School, EFIC School 2019, Translational Pain Research From Lab to clinic
Publication type: conference